Find a Tender
complete
Official procurement procedure
Insulin Infusion Pumps, Continuous Glucose Monitoring Systems and Associated Consumables
Devices and instruments for infusion
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"): "Insulin Infusion Pumps, Continuous Glucose Monitoring Systems and Associated Consumables". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
9.9Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 974 active published awards; 798 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published15 Feb 2023, 14:13 GMT | Last source update15 Feb 2023, 14:13 GMT | Recurring procurementNot published |
ClassificationDevices and instruments for infusion | ||
Delivery area | ||
OCIDocds-h6vhtk-03a5e8 | ||
What is being bought
Insulin Infusion Pumps, Continuous Glucose Monitoring Systems and Associated Consumables
What changed
From the official release history
- Status changed to complete
15 Feb 2023, 14:13 GMT - Official notice release published
15 Feb 2023, 14:13 GMT - Buyer information updated
15 Feb 2023, 14:13 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedSupply of Insulin Infusion Pumps that can be linked to Continuous Glucose Monitoring Systems, along with all associated consumables Supply of Patch or Hybrid Insulin Infusion Pumps along with all associated consumables. Supply of Standard Durable Insulin Infusion Pumps that cannot be linked to CGM Systems and all associated consumables. Supply of Continuous Glucose Monitoring Systems and all associated consumables. Additional information: 4-months Framework Extension to 28th June 2023Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
15 Feb 2023, 14:13 GMT - Award active
Not published · Not published - Contract active
Signed 13 Feb 2023, 00:00 GMT · £3,300,000
Commercial outcome and competition
Awards Advanced Therapeutics UK Ltd, Cellnovo Ltd, Dexcom, Insulet International Ltd, Medtronic Limited, Medtrum Ltd, Roche Diabetes Care, Tandem Diabetes Care, Inc., Ypsomed Ltd Not published · Not published · active |
Contracts Contract £3,300,000 · signed 13 Feb 2023, 00:00 GMT · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Contracting authority GB-FTS-322Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleAward of a contract without prior publication of a call for competition:
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation:
This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector following from the Covid-19 pandemic and to maintain necessary supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015 |